Law360, New York (January 11, 2008, 12:00 AM EST) -- In September 2000, the Centers for Medicare and Medicaid Services released its National Coverage Decision (“the 2000 NCD”) setting forth the Medicare reimbursement policy for clinical trials, in response to President Clinton’s executive memorandum directing that Medicare pay for routine costs associated with participation in clinical trials.
In the last two years, CMS has promulgated draft modifications to the 2000 NCD, but it has not yet adopted any real substantive changes.
This article provides a brief summary of the 2000 NCD and CMS’s series of proposed,...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.